is tirzepatide a glp-1 agonist The dual action of on various organs. GLP-1: How does the simultaneous activation
Description
Endocrinology 151 , 46784687 (2010)
ADVERSE REACTIONS : The most common adverse reactions, reported in 5% of patients treated with Victoza and more commonly than in patients treated with placebo, are: headache, nausea, diarrhea and anti-liraglutide antibody formation
doi: 10.1016/j.diabet.2011.11.004
Primary outcome The primary outcome of this study is the first occurrence of any psychiatric diseases
Boye K, Sapin H, Ling Poon J, Fernandez Lando L, Huh R, Wang M, et al
